Clinical trials
Essential Hypertension trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
53 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2004 | 1 |
| 2007 | 6 |
| 2008 | 5 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 2 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 37 |
| Recruiting | 6 |
| Terminated | 4 |
| Active, not recruiting | 3 |
| Not yet recruiting | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Takeda | 7 |
| Novartis Pharmaceuticals | 5 |
| ReCor Medical, Inc. | 4 |
| Novartis | 3 |
| Columbia University | 2 |
| PhaseBio Pharmaceuticals Inc. | 2 |
| Roxane Laboratories | 2 |
| University of Texas Southwestern Medical Center | 2 |
| Wake Forest University Health Sciences | 2 |
| Ablative Solutions, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Essential Hypertension | 53 |
| Hypertension | 35 |
| Cardiovascular Diseases | 15 |
| Vascular Diseases | 8 |
| Hyperlipidemias | 2 |
| Obesity | 2 |
| Anxiety Disorders | 1 |
| Arthritis | 1 |
| Chronic Pain | 1 |
| Diabetes Mellitus | 1 |
Trials
Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.